Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Acquisitions (2019)

Updated

Oncotelic Therapeutics (OTLC) reported Acquisitions of $6,403 for Q4 2019.

Analysis

Oncotelic Therapeutics (OTLC) Acquisitions (2019) Analysis & Trends

For FY2019, Oncotelic Therapeutics posted Acquisitions of $189,286.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -17.24 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 11.21 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -6,403.00
API Access

Oncotelic Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=OTLC&period=max&api_key=YOUR_API_KEY